Plasmodium vivax the first-line treatment for "P. falciparum" malaria, it may also be used for P. vivax malaria in combination with primaquine for radical cure. An exception is artesunate plus sulfadoxine-pyrimethamine (AS+SP), which is not effective against P. vivax in many places. Mefloquine is a good alternative and in some countries is more readily available. Atovaquone-proguanil is an effective alternative in patients unable to tolerate chloroquine. Quinine may be used to treat "vivax" malaria but is associated with inferior outcomes. 32–100% of patients will relapse following successful treatment of "P. vivax" infection if a radical cure (eradication of liver stages) is not
Israel Center for the Treatment of Psychotrauma Israel Center for the Treatment of Psychotrauma The Israel Center for the Treatment of Psychotrauma (ICTP) affiliated with Herzog Hospital in Jerusalem, Israel, is a community-based trauma center The Israel Center for the Treatment of Psychotrauma was established in 1989 to improve the level of trauma-related services in Israel and around the world. ICTP has developed a comprehensive range of clinical and community-based services. ICTP is today involved in the research and treatment of the widespread effects of trauma caused by terrorism, war and natural disaster. ICTP has been active in its present form since 1989, but draws on a